Clinical trials
Terminated Phase 2 trials in Lebanon
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| American University of Beirut Medical Center | 3 |
| EMD Serono | 3 |
| Cardurion Pharmaceuticals, Inc. | 2 |
| Shire | 2 |
| Allergan | 1 |
| HemaQuest Pharmaceuticals Inc. | 1 |
| Ionis Pharmaceuticals, Inc. | 1 |
| La Jolla Pharmaceutical Company | 1 |
| Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia, Sickle Cell | 4 |
| beta-Thalassemia | 3 |
| Amyotrophic Lateral Sclerosis | 1 |
| Breast Neoplasms | 1 |
| Cholangiocarcinoma | 1 |
| Iron Overload | 1 |
| Neuritis | 1 |
| Optic Neuritis | 1 |
| Thalassemia | 1 |
| Urinary Bladder, Overactive | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.